Form EFFECT Can-Fite BioPharma Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 3, 2026 5:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Can-Fite Secures Japanese Patent Allowance for Namodenoson's Anti-Obesity Technology
- SHIB Price Prediction Faces New Pressure as 2020 Whale Dumps 600 Billion Tokens and Pepeto Presale Crosses $10.3 million
- Crypto News: Pepeto Presale Crosses $10 Million While Solana Price Targets $3,211 on VanEck's Bull Case
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
